A man with Parkinson’s disease saw an easing of his motor and nonmotor symptoms and better fitness after taking…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A protein called NEMO can dock to misfolded forms of alpha-synuclein — the protein whose toxic aggregates damage and kill…
Alpha-synuclein, the protein that builds up into toxic clumps in Parkinson’s disease, may trigger neurons (nerve cells) to increase…
Factors such as exposure to environmental toxins and repeated blows to the head — all of which can be reduced…
Alpha-synuclein — the protein that forms toxic clumps in the brains of people with Parkinson’s disease — may travel…
A ceramic blanket, a device being developed by Gladiator Therapeutics to improve blood flow and speed up wound healing,…
Vanqua Bio will initiate clinical development of VQ-101 — a small molecule capable of penetrating the brain — in…
Low-dose fosgonimeton (ATH-1017), an investigational small molecule, may have cognitive benefits for people with Parkinson’s disease-related dementia or dementia…
Phasing out fossil fuels could save an estimated 5.1 million lives each year worldwide by preventing deaths attributed to ambient…
People with Parkinson’s disease who maintain the recommended level of weekly physical activity tend to be those with critical…